Dupilumab Promising for Children Up to 12 Years Old With EoE Dupilumab Promising for Children Up to 12 Years Old With EoE

New evidence supports the safety and efficacy of dupilumab for children aged 1-12 years with eosinophilic esophagitis.Medscape Medical News
Source: Medscape Allergy Headlines - Category: Allergy & Immunology Tags: Gastroenterology News Source Type: news